← SynDRA
NISOXETINE
SynDRA canonical compound SYN0002256 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | SLC6A2 |
|---|
| Mechanism of action | Norepinephrine reuptake inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Norepinephrine reuptake inhibitor
- SLC6A2 INHIBITOR
- SLC6A3 INHIBITOR
- SLC6A4 INHIBITOR
Cross-references
Synonyms
- Nisoxetina
- COMPOUND-89218
- LY-94939
- NSC-283481
- 3-(2-Methoxyphenoxy)-N-methyl-3-phenylpropylamine
- Compound 89218
- 3-(2-methoxyphenoxy)-N-methyl-3-phenylpropan-1-amine
- Nisoxetine [USAN:INN]
- 3-(o-Methoxyphenoxy)-N-methyl-3-phenylpropylamine
- N-Methyl-gamma-(2-methylphenoxy)phenylpropanolamine
- Lilly 94939
- DL-N-Methyl-3-(o-methoxyphenoxy)-N-methyl-3-phenylpropylamine
- CHEMBL295467
- CHEBI:73410
- ITJNARMNRKSWTA-UHFFFAOYSA-N
- NCGC00015715-04
- Nisoxetine Inhibitor
- DSSTox_RID_80724
- DSSTox_CID_25175
- DSSTox_GSID_45175
- NSC 283481
- 17NV064B2D
- Benzenepropanamine, gamma-(2-methoxyphenoxy)-N-methyl-
- Compound 89218; NSC 283481
- Nisoxetinum
- CAS-53179-07-0
- LY 94939
- UNII-17NV064B2D
- NISOXETINE [INN]
- ANTIOXIDANT1425
- Nisoxetine (USAN/INN)
- Prestwick0_000910
- Prestwick1_000910
- Prestwick2_000910
- Prestwick3_000910
- NISOXETINE [USAN]
- Lopac0_000901
Look up NISOXETINE in the interactive SynDRA portal →